Nachrichten zur Vertex Pharmaceuticals Aktie

Getting dizzy from the stock markets gyrations? Join the club. The major market indexes are behaving like a frantic yo-yo,…

Vertex Pharmaceuticals (VRTX) closed at $492.47 in the latest trading session, marking a +0.01% move from the prior day.…

Vertex Pharmaceuticals (NASDAQ: VRTX) had a fine Tuesday on the stock exchange. The biotechs shares closed the day nearly 3%…

When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects. However,…

President Trump isnt a fan of Fed Chairman Jerome Powell, despite nominating Powell to replace Janet Yellen in 2017. Trump…

A "monster stock" might be one that frightens you by free-falling. Or it might alarm you with characteristics such as…

Equity markets have been seesawing for the past two weeks. Stocks fell hard after President Donald Trump announced his tariff…

Yo-yos are fun for kids. But yo-yo stock markets arent so fun for grown-up investors. And unfortunately, theres been a…

When the stock market is as turbulent as it is these days, its easy to forget the times when things…

"May you live in interesting times." That probably isnt an ancient Chinese curse as some think. However, many investors might wish…

Vertex Pharmaceuticals (NASDAQ: VRTX) is a great example of biotech success. The company has built a cystic fibrosis (CF) empire,…

Vertex Pharmaceuticals (VRTX) reachead $475.49 at the closing of the latest trading day, reflecting a -1.41% change compared to its…

Equity markets may be struggling because of President Donald Trumps current economic policies, but that doesnt mean investors should avoid…

Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex…

As biotech investors know, companies in the industry can sometimes earn significant returns in relatively short periods, like a year,…

Stocks are sinking the most since the COVID-19-fueled sell-off in 2020. A global trade war seems imminent. JPMorgan Chase just…

…

Which group of individuals is in the best position to spot early warning signs of economic trouble? Theres a good…

Vertex Pharmaceuticals (VRTX) reachead $484.01 at the closing of the latest trading day, reflecting a +0.11% change compared to its…

Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $492.69, signifying a -1.96% move from its prior days close.…

Vertex Pharmaceuticals (VRTX) closed at $502.55 in the latest trading session, marking a +0.45% move from the prior day.…

While the recent market dip has created bargains, some stocks have sufficiently lagged the market in the past year to…

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close.…

In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $512.52, indicating a +0.06% shift from the previous trading…

Equity markets started 2025 pretty well, but things havent been so rosy in the past couple of months. The tech-heavy…

Vertex Pharmaceuticals (VRTX) ist als Marktführer zur Behandlung von zystische Fibrose (CF) bisher stark vom Kernprodukt TRIKAFTA mit 93 %…

Are you reluctant to invest in stocks right now? Thats understandable. Fear, uncertainty, and doubt have become the norm in…

Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $502.92, signifying a +1.51% move from its prior days close.…

Vertex Pharmaceuticals (VRTX) reachead $495.29 at the closing of the latest trading day, reflecting a +1.42% change compared to its…

The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its first…

There are hundreds of publicly traded companies on various equity markets worldwide. Investors choose to put their hard-earned money into…

Am 07. März 2025 gab Vertex Pharmaceuticals Inc. bekannt, dass die britische Regulierungsbehörde für Arzneimittel und Gesundheitsprodukte (MHRA) die Zulassung…

Its often challenging to decide which stocks to invest in. However, some companies look too attractive to pass up. We…

2025 has gotten off to a choppy start as some of the most valuable U.S.-based companies are dragging down the…

Biotech companies can skyrocket in a short period because of excellent clinical or regulatory progress. And if we take the…

Dr. Reshma Kewalramani, Vertex Pharmaceuticals CEO, leads the first biotech to win approval for a therapy using CRISPR gene editing…

In a sense, every investor is a growth investor. Even those who are primarily seeking income enjoy when the stocks…

Looking for a good area in which to invest? Consider the healthcare sector. People must have healthcare. And with aging…

If youre content with market-level returns, investing in an exchange-traded fund (ETF) is the way to go. But if not,…

Vertex Pharmaceuticals (NASDAQ: VRTX) and AstraZeneca (NASDAQ: AZN), two of the worlds leading drugmakers, missed last years strong market rally.…

Healthcare isnt the hottest sector these days. While the S&P 500 has soared nearly 21% over the last 12 months,…

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for…

Vancouver (www.aktiencheck.de) - Rating-Update: Canaccord hat die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN: 882807, Ticker-Symbol: VX1, NASDAQ-Symbol: VRTX) von…

On Hump Day, investors piled into CRISPR Therapeutics (NASDAQ: CRSP) stock, sending its price more than 9% higher at the…

New York (www.aktiencheck.de) - Rating-Update: Terence Flynn, Analyst von Morgan Stanley, stuft die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN:…

Heres our initial take on Vertex Pharmaceuticals (NASDAQ: VRTX) fourth-quarter financial report. Key Metrics Metric Q4 2023 Q4 2024 Change vs. Expectations Revenue $2.52 billion $2.91 billion 16% Beat Earnings per share $3.71 $3.50 -6% Missed Trikafta/Kaftrio…

Das US-Biotech-Unternehmen Vertex Pharmaceuticals hat am Montag nach US-Börsenschluss seine Zahlen für das vierte Quartal vorgelegt. Beim Umsatz konnte Vertex…

Das US-Biotech-Unternehmen Vertex Pharmaceuticals hat am Montag nach US-Börsenschluss seine Zahlen für das vierte Quartal vorgelegt. Beim Umsatz konnte Vertex…

VRTX earnings call for the period ending December 31, 2024.…

…